Cost–benefit evaluation of homeopathic versus conventional therapy in respiratory diseases

Methods: A retrospective observational study was conducted on 105 out of 233 patients suffering from chronic respiratory disease attending the Homeopathic Clinic of the Campo di Marte Hospital in Lucca (Tuscany, Italy) between October 1998 and May 2003. We assessed the cost of conventional medicinal products using Anatomic Therapeutic Chemical (ATC) classification, specific for the pathology in question, and the general costs in the year preceding the first appointment at the Homeopathic Clinic vs. the first and second year subsequent to homeopathic treatment. The costs of conventional drugs for a group of patients affected by asthma (8 patients) and recurrent respiratory infections (16 patients) with long term use of conventional medicine treated by homeopathy were compared with the expenses of conventional drugs of a matched group of 16 and 32 patients, respectively.

Results: Costs of pharmacological therapy specific for respiratory diseases were reduced by 46.3% (n = 105) in the first year (P < 0.01); and by 47.5% (n = 72) in the second year (P < 0.01) of homeopathic treatment. Reduction in general drug costs during homeopathic therapy was 42.4% in the first year (P < 0.01); and −49.8 in the second year (N.S.). Costs for patients affected by chronic asthma showed a reduction in expenses of 71.1% for specific medicines relative to the group in homeopathic treatment vs. an increase of 12.3% in the group treated only with conventional drugs after the first year of follow-up and, respectively, a reduction of −54.4% for homeopathic treatment vs. +45.2% after the second year. For patients with recurrent respiratory infections we found a reduction of 35.8% in the homeopathic group in the first year, compared to an increase 8.6% of costs for specific drugs in the control group; in the second year the respective figures were −43.6% versus +7.8% in the control group.

Conclusions: Homeopathic treatment for respiratory diseases (asthma, allergic complaints, Acute Recurrent Respiratory Infections) was associated with a significant reduction in the use and costs of conventional drugs. Costs for homeopathic therapy are significantly lower than those for conventional pharmacological therapy.

Keywords

respiratory disease - asthma - recurrent respiratory infections - allergy - drug consumption - cost effectiveness - public sector - Italy - homeopathy

• References

• 1 Menniti-Ippolito F., Gargiulo L., Bologna E., Forcella E., Raschetti R. Use of unconventional medicine in Italy: a nation-wide survey. Eur J Clin Pharmacol 2002; 58: 61-64.
• 2 Smallwood C. The role of complementary and alternative medicine in the NHS. Available from: www.freshminds.co.uk/pdf/the20%report.pdf [accessed in June 2007].
• 3 Brinkhaus B, Schindler G, Lindner M, Jansen A, Hahn E.G. Socioeconomic aspects of homoeopathy as seen by decision-takers and service providers in the public health system. Homeopathy a critical appraisal, Oxford: Butterworth-Heinemann Reed Educational Professional Publishing Ltd. [chapter 17].
• 4 Chaufferin G. Improving the evaluation of homeopathy: economic consideration and impact on health. Br Homeopath J 89(Suppl. 1): S27–S30.
• 5 Güthlin C., Lange O., Walach H. Measuring the effects of acupuncture and homoeopathy in general practice: an uncontrolled prospective documentation approach. BMC Public Health 2004; 4: 6.
• 6 van Haselen R. The economic evaluation of complementary medicine: a stage at the Royal London Homeopathic Hospital. Br Homeopath J 2000; 89 (01) S23-S26.
• 7 Jain A. Does homeopathy reduce the cost of conventional drug prescribing?. Homeopathy 2003; 92: 71-76.
• 8 Swayne J. The cost and effectiveness of homeopathy. Br Homeopath J 81: 148–150.
• 9 Witt C, Keil T, Selim D, et al. Outcome and costs of homeopathic and conventional treatment strategies; a comparative study in patients with chronic disorders. Complement Ther Med 13(2): 79–86.
• 10 Wassenhoven van M., Ives G. An observational study of patients receiving homeopathic treatment. Homeopathy 2004; 93: 3-11.
• 11 Vickers A.J., Smith C. Homeopathic oscillococcinum for preventing and treating influenza and influenza-like syndromes. Cochrane Library 2001: 1-10.
• 12 Cucherat M., Haugh M.C., Gooch M. et al. Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. Homeopathic Medicine Research Advisory Group. Eur J Clin Pharmacol 2000; 56: 27-33.
• 13 Riley D., Fischer M., Singh B., Haidvogl M., Heger M. Homeopathy and conventional medicine: an outcome study comparing effectiveness in a primary care setting. J Altern Complement Med 2001; 7 (02) 149-159.
• 14 Rezzani CM, WinChip: computerized homeopathic investigation program: a data collection tool to help the doctor in daily practice and a real instrument to prove and improve homeopathy. Proceedings of the International Conference “Improving the success of homeopathy 2. Developing and demonstrating effectiveness” London, 15–16 April 1999; p 32.
• 15 Richardson W.R. Patient benefit survey: Liverpool Regional Department of Homoeopathic Medicine. Br Homeopath J 2001; 90 (03) 158-162.
• 16 Wewers M.E., Lowe N.K. A critical review of visual analogue scales in measurements of clinical phenomena. Research in Nursing & Health 1990; 13: 227-236.
• 17 De Schepper L. LM potencies: one of the hidden treasures of the sixth edition of the Organon. Br Hom J 1999; 88: 128-134.
• 18 WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health concerning the ATC/DDD system. Available from: www.whocc.no/atcddd/ [accessed in June 2007].
• 19 Rossi E., Endrizzi C., Carmela Leone. Patient therapy compliance at ASL district 2 Homoeopathic Clinic, Lucca. Homeopathy 2006; 95: 206-214.
• 20 Jenkinson S.G. Pearls from the National Institutes of Health Asthma Guidelines, Lesson 19 volume 13. Available from: www.chestnet.org/education/online/abim/chart/vol13/lesson19.php [accessed in June 2007].
• 21 Doerr L. Using homeopathy for treating childhood asthma: understanding a family choice. J Pediatr Nurs 2001: 269-276.
• 22 Trichard M., Chaufferin G., Nicoloyannis N. Pharmaeconomic comparison between homeopathic and antibiotic treatment strategies in recurrent acute rhinopharyngitis in children. Homeopathy 2005; 94: 3-9.
• 23 Di Stefano M. MnC, ma quanto mi costi?. Medicina Naturale 2004; 6: 34-37.
• 24 Endrizzi C., Rossi E., Crudeli L., Garibaldi D. Harms in homeopathy: aggravations, adverse drugs events or medication errors?. Homeopathy 2005; 94: 233-240.